基本信息
views: 3
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr Amy Chung is an NHMRC Career Development and Dame Kate Campbell Fellow. She completed her PhD at the University of Melbourne in 2011 and was awarded an American Australian Association Fellowship, NHMRC CJ Martin and MGH Medical Discovery Fellowship to conduct her postdoctoral training at the Ragon Institute of MGH, MIT and Harvard.
She returned to the University of Melbourne in 2015, where she was awarded an amfAR Mathilde Krim Fellowship that supported the establishment of her own laboratory in 2019. Dr Chung's lab aims to continually apply cutting-edge technologies to identify protective antibody responses against infectious diseases. Beyond neutralization, antibodies can mediate an array of functions, by instructing the innate immune system with their Fc region on how to attack pathogens. Dr Chung's work has helped identify key “humoral fingerprints” associated with protection against HIV and Mycobacterium Tuberculosis and is now being applied to other infectious diseases including Malaria and Influenza. This research can be used to design future antibody-based vaccines and can contribute to the generation of improved monoclonal antibody therapeutics.
She returned to the University of Melbourne in 2015, where she was awarded an amfAR Mathilde Krim Fellowship that supported the establishment of her own laboratory in 2019. Dr Chung's lab aims to continually apply cutting-edge technologies to identify protective antibody responses against infectious diseases. Beyond neutralization, antibodies can mediate an array of functions, by instructing the innate immune system with their Fc region on how to attack pathogens. Dr Chung's work has helped identify key “humoral fingerprints” associated with protection against HIV and Mycobacterium Tuberculosis and is now being applied to other infectious diseases including Malaria and Influenza. This research can be used to design future antibody-based vaccines and can contribute to the generation of improved monoclonal antibody therapeutics.
Research Interests
Papers共 147 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Raj Kalkeri,Mingzhu Zhu,Shane Cloney-Clark,Joyce S. Plested,Anand Parekh, Drew Gorinson,Rongman Cai, Soham Mahato,Pradhipa Ramanathan, L. Carissa Aurelia,Kevin John Selva,Anthony M. Marchese,
medrxiv(2024)
Ruth A. Purcell, L. Carissa Aurelia,Robyn Esterbauer,Lilith F. Allen,Katherine A. Bond,Deborah A. Williamson,Janine M. Trevillyan,Jason A. Trubiano, Jennifer J. Juno,Adam K. Wheatley,Miles P. Davenport,Thi H. O. Nguyen,
CLINICAL & TRANSLATIONAL IMMUNOLOGYno. 3 (2024): e1494-e1494
Methods in molecular biology (Clifton, N.J.) (2024): 201-218
NATURE COMMUNICATIONSno. 1 (2024): 3210-3210
Nature immunologyno. 8 (2024): 1355-1366
Wen Shi Lee,Jennifer Audsley, Mai-Chi Trieu,Arnold Reynaldi, L Carissa Aurelia, Palak H Mehta, Joanne Patterson,Helen E Kent,Julie Nguyen,Thakshila Amarasena,Robyn Esterbauer,Ebene R Haycroft,
The Journal of clinical investigation (2024)
Natalie Lorenz,Reuben McGregor,Alana L. Whitcombe,Prachi Sharma,Ciara Ramiah, Francis Middleton,Michael G. Baker, William J. Martin,Nigel J. Wilson,Amy W. Chung,Nicole J. Moreland
iScienceno. 8 (2024): 110558
crossref(2024)
Ophthalmology (2024)
Clinical & translational immunologyno. 6 (2023): e1456-e1456
Load More
Author Statistics
#Papers: 154
#Citation: 5313
H-Index: 36
G-Index: 72
Sociability: 7
Diversity: 0
Activity: 2
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn